The firm revealed this in a declaration released by its Resident Media Consultant, Mr Olusayo Akintola, on Sunday in Abuja.
According to the declaration, the damage works out formed part of NAFDAC’s enforcement accomplishments highlighted at the International Pharmaceutical Regulators Programme (IPRP) Management Committee Meeting kept in Prague, Czech Republic, from November 18 to 19, 2026.
The firm likewise reported 5,542 enforcement activities, 213 raids, 821 item seizures, 179 properties closures, 52 arrests and 221 sanctions within the eight-month duration.
NAFDAC advances regulative capability and digital development
Akintola stated the firm’s discussion at the worldwide conference highlighted turning points in regulative system fortifying, digital development, pharmaceutical production, enforcement and global cooperation.
He kept in mind that NAFDAC had actually sustained its World Health Organisation (WHO) Maturity Level 3 status and was working towards achieving Maturity Level 4, the greatest level under the WHO Global Benchmarking Tool.
The company is likewise releasing digital platforms to enhance its regulative procedures and enhance effectiveness.
These consist of the Integrated Regulatory Information Management System (IRIMS), Performance Management System (i-PMS) and GMP Inspection (GMPi).
Other efforts consist of the Application and AI-assisted Technical-Screening Tools (TST) and the modified Med-Safety App, created to reinforce reporting of substandard and falsified medical items in addition to unfavorable drug responses.
Regional pharmaceutical production records advance
NAFDAC likewise reported development in promoting domestic pharmaceutical production through its 5 +5 Policy, with more than 70% of completed pharmaceutical items and 36 items now in your area made.
The effort is focused on minimizing Nigeria’s reliance on imported medications and reinforcing nationwide medication security.
The firm stated its growing regulative impact throughout Africa was more shown by its introduction as a referral National Regulatory Authority.
As part of this function, NAFDAC hosted regulative authorities from Uganda, The Gambia, Mozambique and Côte d’Ivoire for technical capability structure and institutional benchmarking.
Nigeria likewise validated the African Medicines Agency (AMA) Treaty and transferred its instruments of ratification on October 25, 2026.
According to Akintola, these turning points show the tactical vision and management of NAFDAC’s Director-General, Prof. Mojisola Adeyeye.
He stated the company would continue to reinforce its regulative capability, improve public health security and position Nigeria as a prominent regulative authority in Africa.
Nigeria’s medication security difficulties
NAFDAC’s newest enforcement figures come in the middle of ongoing efforts to take on fake medications, unregistered items and weak points in Nigeria’s pharmaceutical regulative system.
- On September 9, 2026, Nairametrics reported that NAFDAC’s Director-General, Prof. Mojisola Adeyeye, connected Nigeria’s fake medication crisis to longstanding regulative spaces, consisting of weak points in the guideline of patent medication dealerships and the expansion of open drug markets.
Previously, in February 2026, Nairametrics reported that NAFDAC took more than 10 million dosages of phony malaria drugs and cosmetic items valued at around N3 billion at Lagos’ Trade Fair Market.
Discover more from PMN S.P.O.R.T.S - A PRIME MEDIA NETWORK BRAND
Subscribe to get the latest posts sent to your email.





